Search research articles
Contact Us
Filters
Showing results (1-10 of 252) with videos related to
Page
of 26
Sort By:
Alzheimer'S Research & Therapy
|
July 21, 2019
Towards a unified protocol for handling of CSF before β-amyloid measurements
Shorena Janelidze, Erik Stomrud, Britta Brix, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
May 31, 2016
Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study
Erik Stomrud, Lennart Minthon, Henrik Zetterberg, et al.
JAMA Neurology
|
July 18, 2019
Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography
Niklas Mattsson, Sebastian Palmqvist, Erik Stomrud, et al.
Alzheimer'S Research & Therapy
|
June 26, 2010
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
Erik Stomrud, Maria Björkqvist, Sabina Janciauskiene, et al.
Dementia and Geriatric Cognitive Disorders
|
July 12, 2007
Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly
Erik Stomrud, Oskar Hansson, Kaj Blennow, et al.
Nordic Journal of Psychiatry
|
June 21, 2017
Psychometric testing of a Swedish version of the Apathy Evaluation Scale
Maurits Johansson, Per Johansson, Erik Stomrud, et al.
Alzheimer'S Research & Therapy
|
October 3, 2022
Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
Anna Linnéa Svenningsson, Erik Stomrud, Sebastian Palmqvist, et al.
Alzheimer'S Research & Therapy
|
March 27, 2020
The age-related effect on cognitive performance in cognitively healthy elderly is mainly caused by underlying AD pathology or cerebrovascular lesions: implications for cutoffs regarding cognitive impairment
Emma Borland, Erik Stomrud, Danielle van Westen, et al.
Neurology
|
July 14, 2022
Clinically Relevant Changes for Cognitive Outcomes in Preclinical and Prodromal Cognitive Stages: Implications for Clinical Alzheimer Trials
Emma Borland, Chris Edgar, Erik Stomrud, et al.
Dementia and Geriatric Cognitive Disorders
|
June 7, 2008
Cube copying test in combination with rCBF or CSF A beta 42 predicts development of Alzheimer's disease
Peder Buchhave, Erik Stomrud, Siegbert Warkentin, et al.
Page
of 26
Search research articles
Search
Showing results (1-10 of 252) with videos related to
Sort By:
Page
of 26
Alzheimer'S Research & Therapy
|
July 21, 2019
Towards a unified protocol for handling of CSF before β-amyloid measurements
Shorena Janelidze, Erik Stomrud, Britta Brix, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
May 31, 2016
Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study
Erik Stomrud, Lennart Minthon, Henrik Zetterberg, et al.
JAMA Neurology
|
July 18, 2019
Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography
Niklas Mattsson, Sebastian Palmqvist, Erik Stomrud, et al.
Alzheimer'S Research & Therapy
|
June 26, 2010
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
Erik Stomrud, Maria Björkqvist, Sabina Janciauskiene, et al.
Dementia and Geriatric Cognitive Disorders
|
July 12, 2007
Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly
Erik Stomrud, Oskar Hansson, Kaj Blennow, et al.
Nordic Journal of Psychiatry
|
June 21, 2017
Psychometric testing of a Swedish version of the Apathy Evaluation Scale
Maurits Johansson, Per Johansson, Erik Stomrud, et al.
Alzheimer'S Research & Therapy
|
October 3, 2022
Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
Anna Linnéa Svenningsson, Erik Stomrud, Sebastian Palmqvist, et al.
Alzheimer'S Research & Therapy
|
March 27, 2020
The age-related effect on cognitive performance in cognitively healthy elderly is mainly caused by underlying AD pathology or cerebrovascular lesions: implications for cutoffs regarding cognitive impairment
Emma Borland, Erik Stomrud, Danielle van Westen, et al.
Neurology
|
July 14, 2022
Clinically Relevant Changes for Cognitive Outcomes in Preclinical and Prodromal Cognitive Stages: Implications for Clinical Alzheimer Trials
Emma Borland, Chris Edgar, Erik Stomrud, et al.
Dementia and Geriatric Cognitive Disorders
|
June 7, 2008
Cube copying test in combination with rCBF or CSF A beta 42 predicts development of Alzheimer's disease
Peder Buchhave, Erik Stomrud, Siegbert Warkentin, et al.
Page
of 26